ENVALITH
株式会社シーユーシー logo

CUC Inc.

9158Growth MarketServices

株式会社シーユーシー logo
CUC Inc.9158

Governance

The company operates under a Board of Directors with an Audit and Supervisory Committee, comprising 7 directors (including 3 Audit and Supervisory Committee members and 2 outside directors). To prevent conflicts of interest with parent company M3, Inc. (which holds 63.46% of voting rights), the company has established related party transaction management regulations, and a majority of the Board of Directors is composed of members who do not concurrently serve at the parent company.

Nomination Committee

Not Established

Compensation Committee

Established

Risk Management

The Risk and Compliance Committee, chaired by the Representative Director, is convened quarterly to identify, assess, and manage company-wide risks, including sustainability-related risks. A framework has been established whereby the committee's resolutions are reported to the Board of Directors.

Shareholder Returns

Currently no dividend is paid. The company prioritizes retaining internal reserves to fund investments such as new location openings and M&A. It states it will consider profit distribution in the future while taking into account business performance and financial condition, but the timing of any dividend implementation remains undetermined.

Dividend Policy

At present, the company prioritizes strengthening internal reserves and does not pay dividends. It plans to use internal reserves for investments such as the expansion of new Hospice-Type Residence locations and additional acquisitions of podiatry clinics in the United States. Going forward, the company will consider returning profits to shareholders while taking into account each period's business performance and financial condition, but the timing of any dividend implementation remains undetermined. If dividends are paid, they will in principle be a single year-end dividend, with the decision made by the Board of Directors.

Dividend

None

Share Buyback

None

Shareholder Benefits

None

ESG

Under the mission of "Creating hope through healthcare," the company has identified five materialities: well-being of patients and healthcare professionals, creation of innovative medical services, safe and secure provision of healthcare, environmental consideration, and thorough compliance. It is advancing concrete initiatives such as introducing renewable energy at its head office and collecting SCOPE 1 and 2 data, reducing nursing care record work by approximately 20% through the use of generative AI, setting FY2030 targets for the ratio of female managers (30% on a standalone basis and 50% combined across the four main group companies), and obtaining "Kurumin" and "Eruboshi" certifications.

Last updated: June 25, 2026